# Swiss PACK-CXL Multicenter Trial for the Treatment of Infectious Keratitis

> **NCT02717871** · PHASE3 · COMPLETED · sponsor: **University Hospital, Geneva** · enrollment: 35 (actual)

## Conditions studied

- Keratitis; Infectious Disease (Manifestation)

## Interventions

- **DEVICE:** PACK-CXL
- **DRUG:** Cefazolin in combination with either tobramycin or gentamicin
- **DRUG:** Cycloplegic agents (cyclopentolate 1% eye drops)
- **DRUG:** Fluoroquinolones (Besifloxacin ; ciprofloxacin ; gatifloxacin ; levofloxacin ; moxifloxacin ; ofloxacin )
- **DRUG:** Corticosteroids (prednisolone acetate 0.5% or 1% eye drops)

## Key facts

- **NCT ID:** NCT02717871
- **Lead sponsor:** University Hospital, Geneva
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2020-10
- **Final completion:** 2020-10
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2020-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02717871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02717871, "Swiss PACK-CXL Multicenter Trial for the Treatment of Infectious Keratitis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02717871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*